Suzhou Highfine Biotech Co Ltd (301393)

Currency in CNY
58.80
-0.80(-1.34%)
Closed·
301393 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 10 days
301393 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
58.5060.39
52 wk Range
33.2663.80
Key Statistics
Bid/Ask
58.82 / 58.83
Prev. Close
59.6
Open
58.5
Day's Range
58.5-60.39
52 wk Range
33.26-63.8
Volume
2.59M
Average Volume (3m)
3.62M
1-Year Change
54.43%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301393 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
60.00
Upside
+2.04%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Suzhou Highfine Biotech Co Ltd Company Profile

Suzhou Highfine Biotech Co., Ltd. manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China. The company’s products include characteristic amide bonds, building blocks, protein reagents, protein crosslinkers, peptide reagents, protective amino acids, ionic liquids, PROTAC reagents, unnatural amino acids, pharmaceutical reagents of liposomes and lipid nanoparticles, nucleotide reagents, etc. Its products are used in fields of peptide, nucleotide, and pharmaceutical synthesis. The company also exports its products. Suzhou Highfine Biotech Co., Ltd. was founded in 2003 and is based in Suzhou, China.

Industry
Chemicals
Employees
428
Market
China

Compare 301393 to Peers and Sector

Metrics to compare
301393
Peers
Sector
Relationship
P/E Ratio
45.9x31.5x−0.6x
PEG Ratio
1.25−0.170.00
Price/Book
2.8x3.2x2.6x
Price / LTM Sales
12.9x4.9x3.3x
Upside (Analyst Target)
0.3%13.7%39.1%
Fair Value Upside
Unlock−7.7%4.5%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 60.00
(+2.04% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.30%
Dividend Yield
0.65%
Industry Median 1.35%
Annualised payout
0.39
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 27, 2025
EPS / Forecast
0.32 / --
Revenue / Forecast
135.21M / --
EPS Revisions
Last 90 days

301393 Income Statement

FAQ

What Stock Exchange Does Suzhou Highfine Biotech Trade On?

Suzhou Highfine Biotech is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Suzhou Highfine Biotech?

The stock symbol for Suzhou Highfine Biotech is "301393."

What Is the Suzhou Highfine Biotech Market Cap?

As of today, Suzhou Highfine Biotech market cap is 6.30B.

What Is Suzhou Highfine Biotech's Earnings Per Share (TTM)?

The Suzhou Highfine Biotech EPS (TTM) is 1.30.

When Is the Next Suzhou Highfine Biotech Earnings Date?

Suzhou Highfine Biotech will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is 301393 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Suzhou Highfine Biotech Stock Split?

Suzhou Highfine Biotech has split 0 times.

How Many Employees Does Suzhou Highfine Biotech Have?

Suzhou Highfine Biotech has 428 employees.

What is the current trading status of Suzhou Highfine Biotech (301393)?

As of 19 Aug 2025, Suzhou Highfine Biotech (301393) is trading at a price of 58.80, with a previous close of 59.60. The stock has fluctuated within a day range of 58.50 to 60.39, while its 52-week range spans from 33.26 to 63.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.